NUCLEOLIN and infection: In subsequent studies, we showed that targeting nucleolin with the DNA aptamer, AS1411, originally developed as a cancer therapeutic, could not only reduce infection of cells in culture, but in two animal models with a corresponding reduction of lung inflammation [5].